Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive, and fatal neurodegenerative disease characterized by loss of motor neurons in the brain and spinal cord. On April 27, AMCP convened an expert panel of clinical and managed care stakeholders to increase understanding on how payers can inform strategies to improve the care and treatment of those impacted by ALS.
June 2023 Legislative & Regulatory Briefing: AMCP Advocates Visit Congress for Legislative Days 2023; AMCP Submits Comments on Manufacturer Discount Program Draft Guidance; AMCP to Showcase Prescription Digital Therapeutics (PDTs) on Capitol Hill; AMCP Comments on Proposed Rules Regarding Privacy and Health Data; AMCP, Health Care Organizations Thank the Biden Administration for Relaunching the Cancer Moonshot.
On April 18, HHS' Office of the National Coordinator for Health Information Technology released a proposed rule titled "Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing." AMCP submitted comments in response to the proposed rule on June 20.
In April, the Department of Health and Human Services published a proposed rule titled "HIPAA Privacy Rule to Support Reproductive Health Care Privacy." AMCP took the opportunity to submit comments and suggestions in support of the rule on June 16.
On May 12, CMS released new draft guidance on the Manufacturer Discount Program, enacted into law as part of the Inflation Reduction Act of 2022 (IRA). In response to the draft guidance, AMCP submitted comments on June 12. In the comment letter, AMCP urges CMS to continue to take precautions against potential unintended consequences throughout its implementation of the IRA.
The AMCP Format public comment period facilitates an exchange of information between manufacturers and health care decision-makers to inform formulary and coverage decisions.
May 2023 Legislative & Regulatory Briefing: AMCP’s Jennifer Mathieu Shares Tactics for Expanding Access to PDTs; ICYMI: Law CPE Sessions from AMCP 2023 Now Available on AMCP Learn; AMCP Submits Comments on Race and Ethnicity Statistical Standards; CMS Issues Final Medicare Part D DIR Reporting Guidance; Register Your Organization for the AMCP IRA Workshop Series.